These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2600792)

  • 1. Center of gravity of drug level curves: a model-independent parameter useful in bioavailability studies.
    Veng-Pedersen P; Tillman LG
    J Pharm Sci; 1989 Oct; 78(10):848-54. PubMed ID: 2600792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. IV. Exact relationship between the terminal log-linear slope parameter beta and drug clearance.
    Veng-Pedersen P; Gillespie WR
    J Pharmacokinet Biopharm; 1987 Jun; 15(3):305-25. PubMed ID: 3668806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An algorithm and computer program for deconvolution in linear pharmacokinetics.
    Veng-Pedersen P
    J Pharmacokinet Biopharm; 1980 Oct; 8(5):463-81. PubMed ID: 7252791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of racemic ibuprofen and its lysinate from suppositories in rabbits.
    Hermann TW; Gtówka FK; Garrett ER
    J Pharm Sci; 1993 Nov; 82(11):1102-11. PubMed ID: 8289122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mean residence time for drugs subject to enterohepatic cycling.
    Shepard TA; Lockwood GF; Aarons LJ; Abrahams ID
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):327-45. PubMed ID: 2810071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence of Bioavailability on Mean Absorption Time: What Does It Tell Us?
    Weiss M; Siegmund W
    AAPS J; 2023 Apr; 25(3):36. PubMed ID: 37016156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cimetidine in dogs after oral administration of cimetidine tablets.
    Le Traon G; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2009 Jun; 32(3):213-8. PubMed ID: 19646084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stochastic interpretation of linear pharmacokinetics: a linear system analysis approach.
    Veng-Pedersen P
    J Pharm Sci; 1991 Jul; 80(7):621-31. PubMed ID: 1941557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theoretical model for both saturable rate and extent of absorption: simulations of cefatrizine data.
    Couet WR; Reigner BG; Guedes JP; Tozer TN
    J Pharmacokinet Biopharm; 1991 Jun; 19(3):271-85. PubMed ID: 1875282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of mean residence-time concepts to pharmacokinetic systems with noninstantaneous input and nonlinear elimination.
    Cheng HY; Jusko WJ
    Pharm Res; 1989 Jan; 6(1):4-12. PubMed ID: 2717515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug absorption evaluation in the presence of changes in clearance: an algorithm and computer program for deconvolution with exact clearance correction.
    Veng-Pedersen P
    Biopharm Drug Dispos; 1987; 8(2):185-203. PubMed ID: 3593898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers.
    Burkhardt O; Stass H; Thuss U; Borner K; Welte T
    Clin Pharmacokinet; 2005; 44(9):969-76. PubMed ID: 16122283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.
    Cheung BW; Cartier LL; Russlie HQ; Sawchuk RJ
    Fundam Clin Pharmacol; 2005 Jun; 19(3):347-54. PubMed ID: 15910659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel extravascular input function for the assessment of drug absorption in bioavailability studies.
    Weiss M
    Pharm Res; 1996 Oct; 13(10):1547-53. PubMed ID: 8899849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel method of calculating absolute bioavailability in nonlinear pharmacokinetics.
    Veng-Pedersen P
    J Pharm Sci; 1985 Jan; 74(1):90-3. PubMed ID: 3981428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption.
    Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part I).
    Veng-Pedersen P
    Clin Pharmacokinet; 1989 Nov; 17(5):345-66. PubMed ID: 2684472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.